According to Bloomberg, the FDA said in a statement that ingesting aspirin on a regular basis isn't recommended to people who have never experienced a cardiovascular event because the drug raises a person's risk of experiencing stomach and brain bleeds.
Even people who are at high risk for cardiovascular disease, but haven't experienced any symptoms yet, should refrain from taking the drug as a preventative measure, they said.
In short, the benefits of the drug only outweigh the risks in cases where people have already experienced a stroke or a heart attack.
The announcement was prompted by the FDA's decision last week to block pharmaceutical company Bayer AG from changing the drug's labeling.
The proposed changes would have allowed the company to market aspirin as a heart attack prevention drug for people who don't have heart problems.
Return to News Home